BASEL, Switzerland, Sept. 16, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) shared real-world evidence from the rollout of Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution ...
Roche Holding RHHBY recently announced that it has received the CE Mark for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution. With the approval, CGM solution can now be made ...
Health Canada has issued a recall for some Accu-Chek Guide devices due to inaccurate blood glucose readings. Certain units of the medical measurement device incorrectly display blood glucose levels, ...
Roche (RHHBY) said it shared real-world evidence from the rollout of Accu-Chek SmartGuide continuous glucose monitoring solution at the European Association for the Study of Diabetes annual meeting on ...
Roche announced its partnership with the digital therapeutic company Wellthy Therapeutics to offer users of the Accu-Chek Active system, a clinically validated artificial intelligence-based digital ...
The integration of Accu-Chek SmartGuide's AI-enabled predictive CGM with the popular mySugr app delivers a simple, intuitive solution for people to manage their diabetes with greater ease. Accu-Chek ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback